Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 120 participants.
Also called NCT01230918
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT01230918
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01230918. Allocation not applicable; no masking; primary purpose diagnostic. Start 2011-05 (registry gives no type); primary completion 2017-04-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
- Acronym
- SCAR
- Condition
- Hypertrophic Cardiomyopathy
- Condition
- Acute Coronary Syndrome
- Intervention (Radiation)
- 99mTc-NC100692
- Lead sponsor
- Ottawa Heart Institute Research Corporation
Record details
- Record id
cardio:ct-nct01230918- Content hash
317d6b6a67cb2d66d93f341d8eaf8e32c43efd5e8402d0d433cf79f80da87a85